Cortisone acetate

DB01380ApprovedInvestigationalSmall moleculeCorticosteroids

Cortisone acetate is a steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones. Cortisone acetate was first isolate in 1935 and became more widely researched in 1949.

Chemical structure of Cortisone acetate
Mechanism
Curator reviewed · 5 references
Primary indication
Cortisone acetate is indicated to treat a wide variety of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases and disorders.Curator reviewed · 61 structured indications
Formula / weight
C23H30O6 · 402.4807 g/mol (avg)
First approval
Canada, 2019 · United States, 1972
Also known as
Cortone acetate

Resolves to

Structure
InChIKeyITRJWOMZKQRYTA-RFZYENFJSA-NSMILES[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C

What you can answer from here — as of September 12, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,263Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
61Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
16Marketed productsAcross 4 countries and 11 labellers
Sign in
32+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cortisone acetate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account